These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3942837)

  • 1. Enhanced survival of sickle erythrocytes upon treatment with glyceraldehyde.
    Benjamin LJ; Manning JM
    Blood; 1986 Feb; 67(2):544-6. PubMed ID: 3942837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent chemical modifiers of sickle cell hemoglobin.
    Ueno H; Bai Y; Manning JM
    Ann N Y Acad Sci; 1989; 565():239-46. PubMed ID: 2774426
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the understanding of sickle cell anemia.
    Charache S
    Hosp Pract (Off Ed); 1986 Feb; 21(2):173-8, 182-90. PubMed ID: 2419352
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.
    Nigen AM; Manning JM
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):367-71. PubMed ID: 264689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of deoxyhemoglobin S polymerization by glyceraldehyde.
    Acharya AS; Sussman LG; Jones WM; Manning JM
    Anal Biochem; 1984 Jan; 136(1):101-9. PubMed ID: 6711801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of sickle cell survival by dimethyl adipimidate is compromised by immune sensitization.
    Guis MS; Lande WM; Mohandas N; Pennathur-Das R; Preisler H; Lubin BH; Mentzer WC
    Blood; 1984 Jul; 64(1):161-5. PubMed ID: 6733268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane modifiers in sickle cell disease.
    Benjamin LJ
    Ann N Y Acad Sci; 1989; 565():247-61. PubMed ID: 2672964
    [No Abstract]   [Full Text] [Related]  

  • 10. New Approaches to the therapy of sickle cell disease.
    Luskey KL; Schechter AN; Hercules JI
    Tex Rep Biol Med; 1980-1981; 40():305-12. PubMed ID: 6172868
    [No Abstract]   [Full Text] [Related]  

  • 11. Anion transport in normal erythrocytes, sickle red cells, and ghosts in relation to hemoglobins and magnesium.
    Teti D; Venza I; Crupi M; Busà M; Loddo S; Romano L
    Arch Biochem Biophys; 2002 Jul; 403(2):149-54. PubMed ID: 12139963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo survival studies of 51Cr-labeled methyl acetimidate treated erythrocytes in patients with sickle cell disease.
    Gabuzda TG; Chao TL; Berenfeld MR; Gelbart T
    Blood; 1980 Dec; 56(6):1041-7. PubMed ID: 7437511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease.
    Noguchi CT; Schechter AN
    Blood; 1981 Dec; 58(6):1057-68. PubMed ID: 7030432
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of oxygen affinity and gelation of hemoglobin S crosslinked by reaction with methyl acetimidate.
    Chao TL; Berenfeld MR; Gelbart T; Gabuzda TG
    Hemoglobin; 1981; 5(1):47-72. PubMed ID: 7204094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.